Coronary Artery Disease
Conditions
Interventions
Drug Exposure Group:None
Sponsors
Shijiazhuang People’s Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1.Age 18–80 years;2.Diagnosed with chronic coronary syndrome or stable CAD;3.Presence of atherosclerotic lesions confirmed by coronary CTA or coronary angiography;4.Baseline blood sample collection and relevant assessments can be completed within 24 hours of admission;5.The patient or their legal representative signs the informed consent form.
Exclusion criteria
Exclusion criteria: 1.Acute infection, severe trauma, active malignancy, or autoimmune disease;2.Recent use of potent anticoagulants preventing reliable coagulation assessment;3.Severe hepatic or renal dysfunction, or contraindication to SGLT2 inhibitors;4.Pregnant or breastfeeding women;5.Recent major bleeding events.6.Severely incomplete clinical data or inability to complete follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prothrombotic State-Related Indicators; | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of major adverse cardiovascular events; | — |
Countries
China
Contacts
Public ContactQin Xiaoyue
Shijiazhuang People’s Hospital
Outcome results
None listed